England - London • Industry focus
DLA Piper
We only have limited information for this firm. Consider the following firms which have provided more information:
DLA Piper‘s practice represents a number of notable clients, including Cancer Research UK, Fresenius Medical Care, and QMD. Richard Taylor leads the team, and has vast expertise in advising SMEs and public bodies on both transactional and contentious IP matters involving supply chains, data, and medical devices. Dylan Kennett has broad experience in domestic and international M&A, and private equity transactions within the cannabis sector.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘They cover all angles, they are across all the new tech and the new developments as much as they are au fait with the well-trodden paths of how to do the big deals. We are indebted to them.’
‘Easy to work with, pragmatic, global support and global network that can give us advice in the jurisdictions we need.'
Abbreviated data is displayed for this firm.
Key clients
- Intercept Pharma
- Philip Morris International
Abbreviated data is displayed for this firm.
Work highlights
- Advised longstanding FTSE 100 client Dechra Pharmaceuticals PLC on its £184m equity fundraising to supports its M&A strategy, which included a cash acquisition of US-based pet health company Piedmont Animal Health Inc.
- Represented Philip Morris International during its contested UK public takeover of Vectura Group plc, the recommended public offer of the oral nicotine manufacturer Swedish Match AB (and associated $6bn bond issuance) with an approximate combined transaction value of over $17bn.
Abbreviated data is displayed for this firm.